Virion Therapeutics to Present Long — Term Follow — Up Data of VRON — 0200 Treatment in Chronic Hepatitis B in a Late — Breaking Oral Presentation at AASLD The Liver Meeting® 2026
For best results when printing this announcement, please click on link below: Virion Therapeutics to Present Long-Term Follow-Up Data of VRON-0200 Treatment in Chronic Hepatitis B in a Late-Breaking Oral Presentation at AASLD The Liver Meeting(®) 2026 Virion Therapeutics, LLC, a clinical-stage biotechnology company, de